Acknowledging she was genetically predisposed to cancer, Kelly Osbourne said, “Apple doesn’t fall too far from the tree.” ...

North Carolina State University's College of Education, one of the departments that was housed in Poe Hall, is allowing ...

CHICAGO -- Germline variations did not predict the risk of taxane-induced peripheral neuropathy (TIPN) in a phase II trial ...

A MUM who thought her back pain was from sitting at a desk all day was later diagnosed with incurable cancer. Izzie Collins ...

In the HERCULES trial, pembrolizumab with platinum-based therapy showed promising safety and efficacy in the treatment of ...

An eGFR cutoff of 75 mL/min/1.73 m2 after 1 year of treatment was predictive of progression to chronic kidney disease among patients with lupus nephritis.

LONDON, United Kingdom – June 3, 2024 – Today, invoX Pharma Limited (“invoX”), a research-driven global biopharmaceutical company with an advancing pipeline of innovative products, has presented ...

Note: Estimates are model-based four-year ahead projections and rounded to the nearest 10. Data: American Cancer Society. Chart: Jared Whalen/Axios With summer approaching, it's time to double down on ...

Rep. Sheila Jackson Lee (D-Texas) has been diagnosed with pancreatic cancer and will occasionally be absent from Congress while she undergoes treatment, the lawmaker said in a statement on Sunday ...

A study found that enfortumab vedotin with pembrolizumab significantly improves survival and maintains quality-of-life ...

“The PRO data presented here complements the published clinical efficacy and safety data, add the patient's voice, and ...

Suspension of treatment in patients with biochemically recurrent (BCR) nonmetastatic hormone-sensitive prostate cancer (nmHSPC) responding well to enzalutamide (Xtandi) regimens had no meaningful ...